|
|
| | butyl-delta(8)-tetrahydrocannabinol Basic information |
| Product Name: | butyl-delta(8)-tetrahydrocannabinol | | Synonyms: | butyl-delta(8)-tetrahydrocannabinol;6H-Dibenzo[b,d]pyran-1-ol, 3-butyl-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-, (6aR-trans)- (9CI);Δ8-THCB (exempt preparation);Δ8-THCB | | CAS: | 51768-59-3 | | MF: | C20H28O2 | | MW: | 300.44 | | EINECS: | | | Product Categories: | | | Mol File: | 51768-59-3.mol |  |
| | butyl-delta(8)-tetrahydrocannabinol Chemical Properties |
| solubility | Acetonitrile: 10 mg/ml |
| | butyl-delta(8)-tetrahydrocannabinol Usage And Synthesis |
| Description | Δ8-THCB (exempt preparation) is an analytical reference standard that is structurally similar to known phytocannabinoids. Δ8-THCB is regulated as a Schedule I compound in the United States. Δ8-THCB (exempt preparation) is provided as a DEA exempt preparation. This product is intended for research and forensic applications. | | Uses | Δ8-THCB (8-Tetrahydrocannabutol) is a structural analog of phytocannabinoids. Δ8-THCB is also an analog of Δ8-tetrahydrocannabinol[1]. | | References | [1] Tagen M, et al. Review of delta-8-tetrahydrocannabinol (Δ8 -THC): Comparative pharmacology with Δ9 -THC. Br J Pharmacol. 2022 Aug;179(15):3915-3933. doi: 10.1111/bph.15865. Epub 2022 Jun 1. Erratum in: Br J Pharmacol. 2023 Jan;180(1):130. DOI:10.1111/bph.15865 |
| | butyl-delta(8)-tetrahydrocannabinol Preparation Products And Raw materials |
|